Cargando…
Perspectives of Genome-Editing Technologies for HIV Therapy
Background: Current HIV antiretroviral therapies potently suppress virus replication and prevent patients from progressing to AIDS but are unable to completely eliminate HIV due to the existence of dormant viral reservoirs which threaten to reemerge at anytime. Recently, genome-editing technologies...
Autores principales: | Ebina, Hirotaka, Gee, Peter, Koyanagi, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384355/ https://www.ncbi.nlm.nih.gov/pubmed/26255882 http://dx.doi.org/10.2174/1570162X13666150807105718 |
Ejemplares similares
-
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
por: Ebina, Hirotaka, et al.
Publicado: (2013) -
A High Excision Potential of TALENs for Integrated DNA of HIV-Based Lentiviral Vector
por: Ebina, Hirotaka, et al.
Publicado: (2015) -
Current status and perspectives of genome editing technology for microalgae
por: Jeon, Seungjib, et al.
Publicado: (2017) -
Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy
por: Gee, Peter, et al.
Publicado: (2017) -
Genome-editing Technologies for Gene and Cell Therapy
por: Maeder, Morgan L, et al.
Publicado: (2016)